Article
Pharmacogenomic polygenic risk score for clopidogrel responsiveness among Caribbean Hispanics: A candidate gene approach.
Clinical and translational science - 1 Nov 2021
Duconge Jorge, Santiago Ednalise, Hernandez-Suarez Dagmar F, Moneró Mariangeli, López-Reyes Andrés, Rosario Marines, Renta Jessicca Y, González Pablo, Ileana Fernández-Morales Laura, Antonio Vélez-Figueroa Luis, Arce Orlando, Marín-Maldonado Frances, Nuñez Héctor, Melin Kyle, Scott Stuart A, Ruaño Gualberto
Abstract excerpt
This multicenter clinical study was aimed at conducting a targeted pharmacogenomic association analysis of residual on-clopidogrel platelet reactivity in 474 Caribbean Hispanic patients. Platelet reactivity was measured using the VerifyNow P2Y12 assay and clopidogrel resistance was defined as P2Y12 reaction units (PRUs) greater than or equal to 208. Genotyping was performed using the whole-genome Infinium MEGA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
